Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
National guidelines for the judicious use of glycopeptides in Belgium
Read the guideline
Abstract
The 'HICPAC guidelines', published in the USA in 1995 stressed the crucial role of restrictive usage of glycopeptides in the strategy to limit the emergence and spread of resistant enterococci. Because controversy still remains in Belgium on the necessity and feasability of restricting glycopeptide usage, the infectious diseases advisory board (IDAB) developed a consensus statement on the judicious use of glycopeptides in Belgium.